Publications by authors named "Shu-Cheng Wan"

Claim this Profile
E
Erratum: Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma: Erratum.
Xiao-Long Wang, Shuo Wang, Zhi-Zhong Wu, Qi-Chao Yang, Hao Li, Shu-Cheng Wan

Int J Med Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Engineering Multienzyme-Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity".
Liang Zhang, Qi-Chao Yang, Shuo Wang, Yao Xiao, Shu-Cheng Wan

Adv Mater· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.
Meng-Jie Zhang, Jie Liu, Shu-Cheng Wan, Jia-Xing Li, Shuo Wang

Head Neck· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.
Liang Zhang, An Song, Qi-Chao Yang, Shu-Jin Li, Shuo Wang, Shu-Cheng Wan

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Pyroptosis Using AIEgen-Based sp Carbon-Linked Covalent Organic Frameworks.
Liang Zhang, Shu-Cheng Wan, Jianyu Zhang, Meng-Jie Zhang, Qi-Chao Yang, Wu-Yin Wang

J Am Chem Soc· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4 blockade induces tumor pyroptosis via CD8 T cells in head and neck squamous cell carcinoma.
Shuo Wang, Zhi-Zhong Wu, Su-Wen Zhu, Shu-Cheng Wan, Meng-Jie Zhang, Zhi-Yong Wang

Mol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma.
Lei Chen, Shu-Cheng Wan, Liang Mao, Cong-Fa Huang, Lin-Lin Bu

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer.
Qi-Chao Yang, Shuo Wang, Yuan-Tong Liu, An Song, Zhi-Zhong Wu, Shu-Cheng Wan

iScience· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy.
Shu-Cheng Wan, Meng-Jie Ye, Qi-Chao Yang, Tian Zhang, Meng-Jie Zhang, Shuo Wang

Adv Healthc Mater· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer.
Yao Xiao, Liang Mao, Qi-Chao Yang, Shuo Wang, Zhi-Zhong Wu, Shu-Cheng Wan

Oral Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma pyroptosis.
Meng-Jie Zhang, Meng-Yun Liang, Shao-Chen Yang, Xian-Bin Ma, Shu-Cheng Wan, Shuo Wang

Chem Commun (Camb)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer.
Su-Wen Zhu, Mengjie Ye, Xianbin Ma, Zhi-Zhong Wu, Shu-Cheng Wan

Acta Biomater· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering Multienzyme-Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity.
Liang Zhang, Qi-Chao Yang, Shuo Wang, Yao Xiao, Shu-Cheng Wan

Adv Mater· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.
Su-Wen Zhu, Shuo Wang, Zhi-Zhong Wu, Qi-Chao Yang, De-Run Chen, Shu-Cheng Wan

Oral Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Dimensional Covalent Organic Frameworks with Cross-Linked Pores for Efficient Cancer Immunotherapy.
Liang Zhang, Lei-Lei Yang, Shu-Cheng Wan, Qi-Chao Yang, Yao Xiao

Nano Lett· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
Xiao-Long Wang, Shuo Wang, Zhi-Zhong Wu, Qi-Chao Yang, Hao Li, Shu-Cheng Wan

Int J Med Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of PREX1 in oral squamous cell carcinoma indicates poor prognosis.
Shu-Cheng Wan, Hao Wu, Hao Li, Wei-Wei Deng, Yao Xiao

J Mol Histol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis